ah 6809 has been researched along with epoprostenol in 1 studies
Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (epoprostenol) | Trials (epoprostenol) | Recent Studies (post-2010) (epoprostenol) |
---|---|---|---|---|---|
163 | 1 | 49 | 15 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, TL; Sharif, NA | 1 |
1 other study(ies) available for ah 6809 and epoprostenol
Article | Year |
---|---|
Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Topics: Algorithms; Alprostadil; Binding, Competitive; Cell Line; Cell Membrane; Cloning, Molecular; Dinoprost; Dinoprostone; DNA, Recombinant; Dose-Response Relationship, Drug; Epoprostenol; Humans; Ligands; Prostaglandin D2; Prostaglandins E; Radioligand Assay; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Tritium | 2002 |